BHP vs IPX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BHP's Piotroski F-Score of 6/9 indicates stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades significantly above its Graham Number of $27.35 and intrinsic value of $24.78, reflecting a substantial premium. Despite strong profitability metrics like 37.7% operating margin and 21.99% ROE, earnings and revenue growth are sharply negative year-over-year. Analysts consensus is a hold with a $57.00 target, below current price, suggesting limited upside.
IPX exhibits significant fundamental weakness, highlighted by a Piotroski F-Score of 3/9, indicating poor operational health. While the company maintains a strong liquidity position with a Current Ratio of 4.03 and very low debt (D/E 0.04), it is currently plagued by severe profitability issues, including an ROE of -50.42% and a negative forward P/E. There is a stark divergence between the 'Strong Buy' analyst consensus and the actual deterministic data, which shows a bearish technical trend (0/100) and a sharp 6-month price decline of 41.3%.
Compare Another Pair
Related Comparisons
BHP vs IPX: Head-to-Head Comparison
This page compares BHP Group Limited (BHP) and IperionX Limited (IPX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.